CVS Health Files 8-K Report

Ticker: CVS · Form: 8-K · Filed: 2025-09-22T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, filing, financials

TL;DR

CVS filed an 8-K, likely with financial updates. Check for details.

AI Summary

CVS Health Corporation filed an 8-K on September 22, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details about the nature of these events or financial figures within the provided text.

Why It Matters

This filing indicates that CVS Health has submitted a report to the SEC, which may contain material updates or financial information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural report and does not disclose any immediate negative events or financial distress.

Key Players & Entities

FAQ

What specific 'Other Events' are reported in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.

What financial statements or exhibits are included with this filing?

The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided text.

When was this 8-K report filed with the SEC?

This 8-K report was filed on September 22, 2025.

What is the principal executive office address for CVS HEALTH Corporation?

The address of the principal executive offices is One CVS Drive, Woonsocket, Rhode Island, 02895.

What is the Commission File Number for CVS HEALTH Corporation?

The Commission File Number for CVS HEALTH Corporation is 001-01011.

From the Filing

0001193125-25-211349.txt : 20250922 0001193125-25-211349.hdr.sgml : 20250922 20250922161942 ACCESSION NUMBER: 0001193125-25-211349 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250922 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250922 DATE AS OF CHANGE: 20250922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 251330251 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d57621d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2025-09-22 2025-09-22     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2025       CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-01011   05-0494040 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   One CVS Drive , Woonsocket , Rhode Island   02895 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Former name or former address, if changed since last report: N/A     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Section 8 - Other Events Item 8.01 Other Events. On September 22, 2025, Omnicare, LLC (“Omnicare”), a wholly owned indirect subsidiary of CVS Health Corporation (NYSE: CVS), issued a press release announcing that Omnicare and certain of its subsidiary entities (the “Omnicare Entities”) have voluntarily initiated chapter 11 proceedings under the U.S. Bankruptcy Code, in order to resolve issues related to its recent litigation

View on Read The Filing